In 2021, the American College of Chest Physicians released clinical guidelines that suggested reduced dosage of either apixaban or rivaroxaban for extended management of blood clots, noting this ...

Summary Apixaban is an oral ... elimination half-life of 12 hours and has been administered in a twice-daily dosing regimen in clinical trials without the need for anticoagulation monitoring ...

Taho Pharmaceuticals’s apixaban-based oral dissolving strips ... medication is administered by crushing a tablet into water, leading to dosing inaccuracies. Taho Pharmaceuticals CEO Howard ...